← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-ALOfficial filing linked
Tommy Tuberville disclosed SELL $LLY
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2024-05-15
Trade date
2024-04-03
Disclosure lag
42 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 42 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
45 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Tommy Tuberville, but PoliWealth treats it as context - not proof of intent or wrongdoing.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID dda61a64-82ed-4cc8-87e7-ef1d256c6565 · filed 2024-05-15 · disclosed 42d after transaction
Market context
Eli Lilly and Company
Sector: Healthcare
Factual flags
- 5 nearby same-ticker disclosures in the surrounding 30-day window.
- 4 healthcare,pharma / biotech sector trades within 30 days while on relevant committee
- 112 trades filed on 2024-05-15 (batch dump)
- 3 members traded LLY within 7 days (starting 2024-04-03)
- Sits on committee with jurisdiction over healthcare/pharma/biotech sector — traded LLY on 2024-04-03
Member trail
Tommy Tuberville
U.S. Senate · AL
Senate Committee on AgricultureNutritionand ForestrySenate Committee on Armed ServicesSenate Committee on HealthEducation
Ticker trail
$LLY
Eli Lilly and Company
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.